Dr. Reddy's Laboratories (NYSE:RDY) will be laying off 25% of its workforce as the company moves to offset impacts from ...

The leading pharmaceutical major has denied ‘factually incorrect’ media reports claiming it plans to cut workforce costs by ...

A report claimed that employees in the age group of 50-55 years working in Dr Reddy’s research and development (R&D) division ...

Business Standard had reported that several senior executives have been asked to resign amid Revlimid-linked margin strain, a ...

Dr. Reddy's Laboratories Ltd. closed 21.94% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

The fall in Dr. Reddy's share price came after the company announced that it received approximately Rs 2,395-crore show cause ...

FY24 annual report shows it had over 26,000 employees worldwide as of March 2024. That includes 21,757 permanent staff. In ...

Dr. Reddy's Laboratories Ltd. closed 21.90% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr Reddy’s, one of India's leading drug manufacturers and suppliers, caters to 42 markets all over the globe. The company's ...

Pharma major, Dr Reddy’s may cut workforce by 25% as part of its cost cutting initiatives. This is as per a report by ...

The company has also offered voluntary retirement to employees aged 50-55 within its research and development division; ...